Bienta is a trademark for preclinical biology services of Enamine, the world’s largest supplier of drug-like molecules for drug discovery research. Bienta is operating as a Contract Research Organisation (CRO) providing biomolecular screening (HTS) services as well as comprehensive bioanalytical support for drug discovery projects, including in vitro ADMET (absorption, distribution, metabolism, excretion, toxicity) testing as well as pharmacokinetics (PK) and toxicity studies in animals.
Company Details
- Employees
- 28
- Founded
- -
- Address
- Bienta/enamine Ltd., 78 Chervonotkatska Street,ukraine
- Industry
- Research
- Website
- bienta.net
- Keywords
- CRO, drug discovery, ADMET, Pharmacokinetics, Animal studies, Life sciences, Biotechnology, Pharmaceuticals, Medicinal Chemistry, Preclinical studies, Molecular modeling, HTS, Virtual screening, Chemoinformatics, Cell culture, Recombinant protein expression, High Throughput Screening, ADME/DMPK, Mass spectrometry, Bioanalytical services, Assay development, Toxicity testing, Metabolism, Toxicology, ADME-Tox.
- HQ
- Kyiv
Bienta Questions
Bienta's website is bienta.net
Bienta's LinkedIn profile is https://ua.linkedin.com/company/bienta
Bienta has
28 employees.
View email and phone details for 28
employees at Bienta.
Bienta's industry is
Research
Bienta's top competitors are
Chemspace,
Bioinformatics For Ukraine,
Sysbioua,
Enamine Ltd.,
Explogen Llc,
Good Cells,
Enamine Germany,
Drug Hunter,
Preci,
Biolabtech.
Bienta's categories are Research
Bienta's founding year is 2011
